版本:
中国

BRIEF-Roche says data support Esbriet use in idiopathic pulmonary fibrosis

May 24 Roche Holding Ag

* Says new data at ats add to body of evidence for roche's esbriet (pirfenidone) in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐